D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPRT
2276
Westport Fuel Systems
WPRT
$40.8M
| $247K | ﹤0.01% |
+15,932
| New | +$247K |
|
2277
Cleveland-Cliffs
CLF
$5.62B
| $246K | ﹤0.01% |
24,669
-3,360,695
| -99% | -$33.5M |
|
2278
Rafael Holdings
RFL
$47M
| $246K | ﹤0.01% |
19,752
-100,229
| -84% | -$1.25M |
|
|
PVLA
2279
Palvella Therapeutics, Inc. Common Stock
PVLA
$661M
| $246K | ﹤0.01% |
917
+293
| +47% | +$78.6K |
|
2280
Xcel Energy
XEL
$42.8B
| $244K | ﹤0.01% |
4,342
-102,172
| -96% | -$5.74M |
|
2281
Aaon
AAON
$6.83B
| $243K | ﹤0.01% |
7,883
-33,520
| -81% | -$1.03M |
|
2282
Gorman-Rupp
GRC
$1.12B
| $242K | ﹤0.01% |
+7,138
| New | +$242K |
|
2283
Penske Automotive Group
PAG
$12.2B
| $242K | ﹤0.01% |
5,425
-16,097
| -75% | -$718K |
|
|
USX
2284
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $242K | ﹤0.01% |
36,675
+7,312
| +25% | +$48.2K |
|
2285
Fox Class B
FOX
$23B
| $240K | ﹤0.01% |
+6,688
| New | +$240K |
|
2286
Hamilton Beach Brands
HBB
$195M
| $240K | ﹤0.01% |
11,171
+8
| +0.1% | +$172 |
|
2287
Nokia
NOK
$24.6B
| $239K | ﹤0.01% |
41,843
-10,621,606
| -100% | -$60.7M |
|
2288
Viridian Therapeutics
VRDN
$1.62B
| $239K | ﹤0.01% |
5,710
+1,770
| +45% | +$74.1K |
|
2289
Verastem
VSTM
$606M
| $239K | ﹤0.01% |
6,721
-38,272
| -85% | -$1.36M |
|
2290
Power Integrations
POWI
$2.5B
| $237K | ﹤0.01% |
6,788
-3,190
| -32% | -$111K |
|
|
TOUR
2291
Tuniu
TOUR
$109M
| $236K | ﹤0.01% |
49,229
-2,544
| -5% | -$12.2K |
|
|
AIG.WS
2292
DELISTED
American International Group, Inc.
AIG.WS
| $236K | ﹤0.01% |
41,284
| – | – |
|
2293
CRISPR Therapeutics
CRSP
$4.71B
| $234K | ﹤0.01% |
6,552
-18,160
| -73% | -$649K |
|
2294
Rigel Pharmaceuticals
RIGL
$661M
| $234K | ﹤0.01% |
9,103
-2,228
| -20% | -$57.3K |
|
2295
Descartes Systems
DSGX
$9.1B
| $233K | ﹤0.01% |
6,400
-19,600
| -75% | -$714K |
|
|
SCWX
2296
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $232K | ﹤0.01% |
12,606
+600
| +5% | +$11K |
|
2297
Cars.com
CARS
$816M
| $231K | ﹤0.01% |
+10,147
| New | +$231K |
|
2298
Provident Financial Services
PFS
$2.59B
| $231K | ﹤0.01% |
8,939
-4,307
| -33% | -$111K |
|
2299
Brighthouse Financial
BHF
$2.79B
| $228K | ﹤0.01% |
6,290
-9,262
| -60% | -$336K |
|
2300
Liberty Latin America Class C
LILAK
$1.55B
| $228K | ﹤0.01% |
12,447
| – | – |
|